NEMBUTAL SODIUM *
Manufacturer Details
ABBOTT INC
Abbott Laboratories
Pharmacetical Division
Compositions:
Pentobarbital sodium 50mg caps,
|
Strength
|
Rate
|
Packing Style
|
|
|
0.00
|
Tab
|
List of Related Indications:
List Of Drugs:
- Pentobarbital sodium @ Barbiturates short acting
Indication Type Description:
Pharmacology/ Pharmacokinetics
Drug Interaction:
BARBITURATES- INCLUDES- AMOBARBITAL,APROBARBITAL, BUTABARBITAL,MEPHOBARBITAL,METHARBARBITAL, PENTOBARBITAL, PHENOBARBITAL, SECOBARBITAL, REFER PHENOBARBITONE
Indication:
Sedative - hypnotic ( short term treatment of insomnia, since it loseds its effectiveness after 2 weeks
BARBITURATES- INCLUDES- AMOBARBITAL,APROBARBITAL, BUTABARBITAL,MEPHOBARBITAL,METHARBARBITAL, PENTOBARBITAL, PHENOBARBITAL, SECOBARBITAL, REFER PHENOBARBITONE
Adverse Reaction:
Refer - Phenobarbitone/ barbiturates
Contra-Indications:
Refer - Phenobarbitone/ barbiturates
Dosages/ Overdosage Etc:
Indications:
Hypnotic,sedation
Dosage:
Adults- Sedation- 20 mg 3 to 4 times per day Hynotic- 100mg at bed time Children- Sedation- 2 to 6mg/kg/day depending on age and weight Preanesthetic- 2 to 6mg/kg/day(max 100mg) depending on age and weight
Patient Information:
BARBITURATES- INCLUDES- AMOBARBITAL,APROBARBITAL, BUTABARBITAL,MEPHOBARBITAL,METHARBARBITAL, PENTOBARBITAL, PHENOBARBITAL, SECOBARBITAL, REFER PHENOBARBITONE
Pharmacology/ Pharmacokinetics:
Refer Phenobarbitone/ barbiturates
Pregnancy and lactation:
Refer Phenobarbitone/ barbiturates
